SEO URLwww.firestrike.ai/deals/dark-blue-therapeutics-amgen-acquisition-2026-1
acquisitionAnnounced · Jan 7, 2026BiotechSource · SpeculativeArticle · Factual
Amgen acquires Dark Blue Therapeutics
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$840M
Target
Dark Blue Therapeutics
Acquirer
Amgen
Full Acquisition
Status
Completed
Amgen agreed to acquire Dark Blue Therapeutics. Reported deal value: $840M. Status: Completed. Sector: Biotech. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.
Dark Blue Therapeutics , a discovery and development biotech spinout Nasdaq-listed multinational biopharma Amgen
Deal timeline
Announced
Jan 7, 2026 · investorsinhealthcare.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotech with a reported deal value of $840M. Figures and status may change as sources update.
Sources: investorsinhealthcare.com · Primary article · FireStrike proprietary index